HeartSciences Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 14

Employees

  • Stock Symbol
  • HSCS

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.13
  • (As of Friday Closing)

HeartSciences General Information

Description

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.

Contact Information

Formerly Known As
Heart Test Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 550 Reserve Street
  • Suite 360
  • Southlake, TX 76092
  • United States
+1 (682)
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 550 Reserve Street
  • Suite 360
  • Southlake, TX 76092
  • United States
+1 (682)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HeartSciences Stock Performance

As of 13-Nov-2026, HeartSciences’s stock price is $2.13. Its current market cap is $10.6M with 4.97M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.13 $2.26 $1.63 - $5.25 $10.6M 4.97M 168K -$3.21

HeartSciences Financials Summary

As of 31-Jul-2026, HeartSciences has a trailing 12-month revenue of $4.52K.

In Thousands,
USD
TTM 31-Jul-2026 FY 2026 30-Apr-2026 FY 2025 30-Apr-2025 FY 2024 30-Apr-2024
EV 10,782 6,681 4,180 41
Revenue 5 4 4 19
EBITDA (9,320) (8,257) (8,137) (6,156)
Net Income (10,259) (9,142) (8,765) (6,605)
Total Assets 3,737 5,263 4,223 9,503
Total Debt 4,005 3,937 2,985 1,036
Public Fundamental Data provided by Morningstar, Inc. disclaimer

HeartSciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HeartSciences‘s full profile, request access.

Request a free trial

HeartSciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKG
Diagnostic Equipment
Southlake, TX
14 As of 2026

Totowa, NJ
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HeartSciences Competitors (4)

One of HeartSciences’s 4 competitors is VectraCor, a Angel-Backed company based in Totowa, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
VectraCor Angel-Backed Totowa, NJ
Nihon Kohden America Corporation Irvine, CA
GE HealthCare Technologies Corporation Chicago, IL
iRhythm Holdings Formerly VC-backed San Francisco, CA
To view HeartSciences’s complete competitors history, request access »

HeartSciences Patents

HeartSciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3834729-A1 Electrocardiogram-based assessment of diastolic function Active 30-Aug-2019
EP-3834729-B1 Electrocardiogram-based assessment of diastolic function Active 30-Aug-2019
EP-3834729-C0 Electrocardiogram-based assessment of diastolic function Active 30-Aug-2019
US-20250255492-A1 Electrocardiogram-based estimation of echocardiography parameters Pending 30-Aug-2019
WO-2019051473-A1 Time-frequency analysis of electrocardiograms Inactive 11-Sep-2017 G16H50/30
To view HeartSciences’s complete patent history, request access »

HeartSciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HeartSciences Acquisitions (1)

HeartSciences’s most recent deal was a Reverse Merger with Fortitude Mining. The deal was made on 23-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Fortitude Mining 23-Jun-2026 Reverse Merger Other Financial Services
To view HeartSciences’s complete acquisitions history, request access »

HeartSciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view HeartSciences’s complete esg history, request access »

HeartSciences FAQs

  • When was HeartSciences founded?

    HeartSciences was founded in 2007.

  • Where is HeartSciences headquartered?

    HeartSciences is headquartered in Southlake, TX.

  • What is the size of HeartSciences?

    HeartSciences has 14 total employees.

  • What industry is HeartSciences in?

    HeartSciences’s primary industry is Diagnostic Equipment.

  • Is HeartSciences a private or public company?

    HeartSciences is a Public company.

  • What is HeartSciences’s stock symbol?

    The ticker symbol for HeartSciences is HSCS.

  • What is the current stock price of HeartSciences?

    As of 13-Nov-2026 the stock price of HeartSciences is $2.13.

  • What is the current market cap of HeartSciences?

    The current market capitalization of HeartSciences is $10.6M.

  • What is HeartSciences’s current revenue?

    The trailing twelve month revenue for HeartSciences is $4.52K.

  • Who are HeartSciences’s competitors?

    VectraCor, Nihon Kohden America, GE HealthCare Technologies, and iRhythm Holdings are competitors of HeartSciences.

  • What is HeartSciences’s annual earnings per share (EPS)?

    HeartSciences’s EPS for 12 months was -$3.21.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process